Cargando…
Editorial: Observational studies in ADHD: the effects of switching to modified-release methylphenidate preparations on clinical outcomes and adherence
Patients with ADHD may have better adherence to treatment with modified-release methylphenidate (MPH-MR) formulations, which are taken once daily, compared with immediate-release (IR) formulations, which need to be taken several times a day. Data on long-term outcomes such as adherence may be lackin...
Autores principales: | Rothenberger, Aribert, Döpfner, Manfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180558/ https://www.ncbi.nlm.nih.gov/pubmed/21901418 http://dx.doi.org/10.1007/s00787-011-0201-5 |
Ejemplares similares
-
An observational study of once-daily modified-release methylphenidate in ADHD: quality of life, satisfaction with treatment and adherence
por: Rothenberger, Aribert, et al.
Publicado: (2011) -
An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety
por: Döpfner, Manfred, et al.
Publicado: (2011) -
An observational study of once-daily modified-release methylphenidate in ADHD: the effect of previous treatment on ADHD symptoms, other externalising symptoms and quality-of-life outcomes
por: Döpfner, Manfred, et al.
Publicado: (2011) -
An observational study of response heterogeneity in children with attention deficit hyperactivity disorder following treatment switch to modified-release methylphenidate
por: Hautmann, Christopher, et al.
Publicado: (2013) -
Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
por: Breuer, Dieter, et al.
Publicado: (2011)